Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of Chronic
.
Show all posts
Showing posts with label
Treatment of Chronic
.
Show all posts
Friday, May 29, 2026
FDA Approves Rhapsido (remibrutinib) for the Treatment of Chronic Spontaneous Urticaria
›
Novartis announced today that Rhapsido (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult...
›
Home
View web version
